共 131 条
[1]
Carson P(1999)Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-heart failure trial study group J Card Fail 5 178-187
[2]
Ziesche S(2015)Racial/ethnic differences in drug disposition and response: review of recently approved drugs Clin Pharmacol Ther 97 263-273
[3]
Johnson G(2005)Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril JAMA 293 1595-1608
[4]
Cohn JN(1994)Historical background of clinical trials involving women and minorities Acad Med 69 695-698
[5]
Ramamoorthy A(2012)Dialogues on diversifying clinical trials: successful strategies for engaging women and minorities in clinical trials J Womens Health (Larchmt) 21 713-716
[6]
Pacanowski MA(2004)Participation in cancer clinical trials: race-, sex-, and age-based disparities JAMA 291 2720-2726
[7]
Bull J(2008)Cancer clinical trials accrual: missed opportunities to address disparities and missed opportunities to improve outcomes for all Ann Surg Oncol 15 1818-1819
[8]
Zhang L(2018)Representation of minorities and women in oncology clinical trials: review of the past 14 years J Oncol Pract 14 e1-e10
[9]
Wright JT(2007)Cancer mortality in the united states by education level and race JNCI: J Nat Cancer Instit 99 1384-94
[10]
Dunn JK(2004)Cancer disparities by race/ethnicity and socioeconomic status CA: A Cancer J Clin 54 78-93